Back to results
US 2010/0136658 A1Published application
Generation of oncolytic adenoviruses and uses thereof
AssigneeBayer Schering Pharma Aktiengesellschaft
InventorsTerry Hermiston, Irene KUHN
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for the production of onolytic adenoviruses having increased potency and their therapeutic applications for cancer. Recombinant adenoviruses and methods to produce them are provided.
Claims20
A method for isolating an oncolytic adenovirus with enhanced potency toward tumor cells derived from colon, ovarian, lung, prostate, breast or pancreas, when compared with a reference virus, said method comprising
- (a) pooling of a group of adenoviruses, wherein said adenoviruses are selected from the group consisting of the adenoviral serotypes B, C, D, E and F;
- (b) passaging the pooled adenoviral mixture from step (a) on an actively growing culture of tumor cells;
- (c) harvesting the supernatant from step (b);
- (d) infecting a quiescent culture of tumor cells with the supernatant harvested in step (c);
- (e) harvesting the cell culture supernatant from step (d) prior to any sign of CPE;
- (f) infecting a quiescent culture of tumor cells with the supernatant harvested in step (e);
- (g) harvesting the cell culture supernatant from step (f) prior to any sign of CPE;
- and
- (h) isolating a virus from the supernatant of step (g) by plaque purification, wherein the tumor cells in steps (b), (d) and (f) are all grown on, or in, an extracellular matrix.
6 more elements
Dependencies are inferred from the claim text.